Pharmaceutical Strategies Group Announces Strategic Leadership Enhancements to Meet Growing Client Needs

Pharmaceutical Strategies Group ("PSG"), an EPIC company, has added two significant enhancements to its leadership team aimed at further empowering healthcare payers and driving innovation within the pharmacy benefits industry. The company welcomes Mike Sackett as SVP of Financial Analytics, Procurement, and Consulting Strategy and celebrates the well-deserved promotion of Rebekah Gregg to Chief Operating Officer.

"The addition of Mike Sackett to our team and the promotion of Rebekah Gregg mark strategic organizational changes that underscore our commitment to growth and our dedication to providing market-leading solutions," said Michael Lonergan, President of PSG. "With these leadership enhancements, we are better positioned than ever to help our clients navigate the complexities of the pharmacy supply chain, driving both innovation and success."

With nearly a quarter century of experience in pharmacy benefit-related financial analytics, Sackett's career, spanning various leadership roles across several of the industry's top organizations, has equipped him with unparalleled expertise in the financial and economic dynamics of the pharmacy benefits market. As the latest addition to the PSG team, Mike will spearhead the financial analytics, procurement, and audit functions, working closely with the senior leadership team to drive innovation, development, and execution of PSG's financial insight products and services. These efforts aim to enhance strategic decision-making for healthcare payers, ensuring their pharmacy benefit programs align with their overarching goals.

"It is an exciting time in the pharmacy benefits landscape, and I am thrilled to contribute my expertise in pharmacy-related strategy to further enhance our capabilities and drive transformative solutions for our clients," said Sackett. "PSG has been a leader in the pharmacy benefits industry, and I look forward to being a part of its continued success."

In recognition of her expanded role and contribution to the company, Rebekah Gregg has been promoted to the role of Chief Operating Officer. Gregg's time at PSG has been marked by significant growth in her scope and span of control, making this promotion a reflection of her current leadership. As COO, Rebekah will oversee PSG's marketing, research, data analytics, clinical shared services, and product strategy, including Artemetrx, further solidifying PSG's position at the forefront of the industry.

Gregg noted, "I am truly honored to step into the role of COO of PSG. Our organization has a rich legacy of innovation and excellence, and I am excited to help continue that work and contribute to our team's efforts in empowering our clients and shaping the future of pharmacy benefits management."

About Pharmaceutical Strategies Group (PSG)

Pharmaceutical Strategies Group, an EPIC company, relentlessly advocates for clients as they navigate complex and ever-changing drug cost management challenges. PSG functions as a strategic partner through industry-leading intelligence and technologies to realize billions of dollars in drug cost savings for clients every year. www.psgconsults.com